Skip to content
Biodatica
Start free

Investigator

Charles H. Spruck

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · funded by NCI

Companies
4

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$2.1M

Summed across those awards.

First award
Dec 10, 2021

Latest Jul 1, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Discovery of Potent Selective Inhibitors of the Histone Methyltransferase SUV39H1 for the Treatment of Cancer

    $809k

    Jul 1, 2024NCISANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11128604 (opens the source filing in a new tab)

  2. R01

    Targeting ER+ Breast Cancer Through Induced Viral Mimicry

    $446k

    Apr 1, 2022NCISANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11061322 (opens the source filing in a new tab)

  3. R01

    Targeting ER+ Breast Cancer Through Induced Viral Mimicry

    $446k

    Apr 1, 2022NCISANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11308203 (opens the source filing in a new tab)

  4. R01

    Targeting the FBXO44/SUV39H1 Pathway in Cancer

    $446k

    Dec 10, 2021NCISANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11231665 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources